Maryland Lawmakers Targeted Pharmacy Reimbursement Rates
Proposed legislation seeks to stabilize independent pharmacy margins against plan-owned competitors.
Updated on Oct. 10, 2026 in Healthcare
Live Poll
Should your state government intervene to ensure local pharmacies stay open in your area?
Maryland officials are considering new legislation to regulate pharmacy reimbursement rates after years of financial pressure on local operators. The proposal aims to curb losses that have forced some independent pharmacies to reduce operating hours and service capacity.
Why it matters
Pharmacy owners are struggling as reimbursement payments frequently fall below the cost of dispensing common medications. This legislative push aims to prevent the expansion of pharmacy deserts by curbing payment disparities favoring health plan-owned competitors.
In 2024, 118 Maryland neighborhoods were identified as pharmacy shortage areas, impacting over 525,000 residents. Locally, Snow Hill Pharmacy reports annual sales exceeding $5 million but has operated at a $12,000 annual loss for three years.
The players
Snow Hill Pharmacy
An independent local pharmacy operating in a small Maryland town that has faced consecutive annual financial losses.
GAO
A federal non-partisan agency that audits and investigates government spending and administrative policy impacts.
The details
Pharmacy benefit managers currently set the rates paid to independent pharmacies for dispensed drugs, often resulting in payments that do not cover procurement costs. Lawmakers propose using an independent administrator to mandate a standardized fee per prescription claim. This mechanism aims to neutralize the current disparity where integrated health plans secure higher payments for their own pharmacy units than independent retailers receive.
Timeline
118 Maryland neighborhoods were categorized as pharmacy shortage areas during 2024.
The GAO released its report regarding pharmacy reimbursement data in September 2026.
State legislators may introduce formal reimbursement legislation during the next session.
Market Landscape
Maryland's legislative efforts follow findings from the 2026 GAO report on pharmacy reimbursement data that documented payment disparities. The proposed intervention attempts to address broader industry trends of independent pharmacy consolidation and closures.
Operators should monitor the upcoming legislative session for specific fee-schedule proposals that could shift pharmacy revenue models. Those currently operating at a loss should evaluate procurement contracts to identify if reimbursement gaps are tied to specific plan-owned pharmacy clauses.
The takeaway
The widening gap between acquisition costs and reimbursement rates is the primary driver behind current pharmacy service reductions. Owners should track potential fee-standardization bills in the next session as a bellwether for state-level pricing reform.
Further reading
For more on industry shifts, visit the Healthcare section.
Source note: This article includes information reported by WBFF.
Live Poll
Should your state government intervene to ensure local pharmacies stay open in your area?
